The Dana-Farber Cancer Institute (DFCI) ASHP Accredited PGY2 Oncology Pharmacy Residency is a 12-month postgraduate educational and training experience designed to develop advanced knowledge, skills, and leadership in the delivery of pharmaceutical services to patients with cancer. Residents who successfully complete a PGY2 oncology pharmacy residency at Dana-Farber will be prepared to become proficient and board-certified clinical oncology pharmacy practitioners, educators, and leaders. Residents will gain experience in a variety of areas of clinical oncology practice including: inpatient and outpatient adult solid tumor and hematologic malignancies, stem cell transplant/cellular therapies, palliative care, pediatric oncology, ambulatory infusion pharmacy, and investigational dr